1、基于持续12个月随访随机对照试验的Meta分析——探讨根除幽门螺杆菌对消化不良的影响。根除幽门螺杆菌能减轻功能性消化不良患者的相关症状。

J Clin Gastroenterol. 2014 Mar;48(3):241-7. doi: 10.1097/MCG.0b013e31829f2e25.

Efficacy of Helicobacter pylori eradication therapy on functional dyspepsia: a meta-analysis of randomized controlled studies with 12-month follow-up.

Zhao B¹, Zhao J, Cheng WF, Shi WJ, Liu W, Pan XL, Zhang GX

2、不同阿莫西林剂量对基于阿莫西林的三联疗法幽门螺杆菌根除率的影响。基于阿莫西林的标准三联抗幽门螺杆菌方案，阿莫西林至少应为3次/日。

J Clin Pharmacol. 2014 Mar;54(3):258-66. doi: 10.1002/jcph.195. Epub 2013 Oct 22.

Effect of dosing schemes of amoxicillin on eradication rates of Helicobacter pylori with amoxicillin-based triple therapy.

Furuta T¹, Sugimoto M, Yamade M, Uotani T, Sahara S, Ichikawa H, Yamada T, Osawa S, Sugimoto K, Watanabe H, Umemura K.

3、改良的10天、12天、14天序贯疗法与14天四联疗法幽门螺杆菌根除率比较研究。

Eur J Intern Med. 2014 Mar;25(3):224-9. doi: 10.1016/j.ejim.2013.11.006. Epub 2013 Nov 20.

Comparison of Helicobacter pylori eradication rates of standard 14-day quadruple treatment and novel modified 10-day, 12-day and 14-day sequential treatments.

Sapmaz F¹, Kalkan IH², Güliter S¹, Atasoy P³.

4、标准三联疗法联合嗜酸乳杆菌和双歧杆菌对根除幽门螺杆菌和肠道菌群的影响

World J Microbiol Biotechnol.2014 Mar;30(3):847-53.

Effect of Lactobacillus acidophilus and Bifidobacterium bifidum supplementation to standard triple therapy on Helicobacter pylori eradication and dynamic changes in intestinal flora.

Wang YH, Huang Y.

5、含西他沙星的三线补救方案在日本治疗幽门螺杆菌感染的效果。

J Gastroenterol Hepatol. 2014 Mar;29(3):487-93. doi: 10.1111/jgh.12442.

Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan.

Furuta T¹, Sugimoto M, Kodaira C, Nishino M, Yamade M, Uotani T, Sahara S, Ichikawa H, Yamada T, Osawa S, Sugimoto K, Watanabe H, Umemura K

6、幽门螺杆菌在胃内的低酸环境中生存有赖于含镍的金属尿素酶和镍铁-羟化酶。无镍饮食增加幽门螺杆菌的根除率：一项初步研究。

Dig Dis Sci. 2014 Mar 5. [Epub ahead of print]

Nickel Free-Diet Enhances the Helicobacter pylori Eradication Rate: A Pilot Study.

Campanale M¹, Nucera E, Ojetti V, Cesario V, Di Rienzo TA, D'Angelo G, Pecere S, Barbaro F, Gigante G, De Pasquale T, Rizzi A, Cammarota G, Schiavino D, Franceschi F, Gasbarrini A.

7、幽门螺杆菌感染：替代自然疗法与传统疗法的简要概述。

Crit Rev Microbiol. 2014 Mar 10. [Epub ahead of print]

Helicobacter pyloriinfection: A brief overview on alternative natural treatments to conventional therapy.

Parreira P¹, Fátima Duarte M, Reis CA, Martins MC

8、在对克拉霉素和（或）甲硝唑中-低度耐药区，缩短14天混合疗法至10/12天，仍能维持较高的幽门螺杆菌根除率。

Helicobacter. 2014 Mar 11. doi: 10.1111/hel.12113. [Epub ahead of print]

Feasibility of Shortening 14-day Hybrid Therapy While Maintaining an Excellent Helicobacter pylori Eradication Rate.

Wu JY¹, Hsu PI, Wu DC, Graham DY, Wang WM.

9、根除幽门螺杆菌的一线方案可否选择基于左氧氟沙星杀星的三联疗法？：系统评价和Meta分析

Scand J Gastroenterol. 2014 Mar 11. [Epub ahead of print]

Is levofloxacin-based triple therapy an alternative for first-line eradication of Helicobacter pylori? A systematic review and meta-analysis.

Xiao SP¹, Gu M, Zhang GX.

10、一线和二线方案根除治疗后，韩国人幽门螺杆菌的复发和再感染问题

Helicobacter. 2014 Mar 11. doi: 10.1111/hel.12117. [Epub ahead of print]

Helicobacter pyloriRecurrence after First- and Second-Line Eradication Therapy in Korea: The Problem of Recrudescence or Reinfection.

Kim SY¹, Hyun JJ, Jung SW, Koo JS, Yim HJ, Lee SW.

11、法莫替丁能够减轻抗血小板药物引起的胃黏膜损伤，而不减弱抗血小板药物的作用，并且这种作用与是否存在幽门螺杆菌感染及CYP2C19基因型无关

J Clin Pharmacol.2014 Mar 11. doi: 10.1002/jcph.284. [Epub ahead of print]

Prevention of gastric mucosal injury induced by anti-platelet drugs by famotidine.

Uotani T¹, Sugimoto M, Nishino M, Ichikawa H, Sahara S, Yamade M, Iwaizumi M, Yamada T, Osawa S, Sugimoto K, Umemura K, Watanabe H, Miyajima H, Furuta T.

12、回复：一项在土著社区比较序贯疗法与三联疗法根除幽门螺杆菌的随机对照试验

Can J Gastroenterol Hepatol.2014 Mar;28(3):167.

Re: Morse AL, Goodman KJ, Munday R, et al; CANHelp Working Group. A randomized controlled trial comparing sequential with triple therapy for Helicobacter pylori in an Aboriginal community in the Canadian North. Can J Gastroenterol 2013;27(12):701-706.

Morse A.

13、意大利含阿莫西林和克拉霉素的标准7天三联疗法治疗幽门螺旋杆菌感染的有效性降低：10年随访研究。

Panminerva Med.2014 Mar;56(1):57-61.

Decreasing efficacy of the standard seven-day triple therapy containing amoxycillin and clarithromycin in curing Helicobacter pylori infection in clinical setting in Italy: a 10-year follow-up study.

Tursi A¹, Elisei W, Giorgetti G, Picchio M, Brandimarte G.

14、一项随机多中心临床试验：序贯疗法与标准三联疗法治疗幽门螺杆菌感染的比较研究

Am J Gastroenterol.2014 Mar 18. doi: 10.1038/ajg.2014.26. [Epub ahead of print]

A Comparative Study of Sequential Therapy and Standard Triple Therapy for Helicobacter pylori Infection: A Randomized Multicenter Trial.

Zhou L¹, Zhang J², Chen M³, Hou X⁴, Li Z⁵, Song Z⁶, He L⁷, Lin S⁶.

 

15、初级保健医生在慢性胃肠道疾病的诊断和治疗中的作用

Int J Gen Med.2014 Mar 13;7:159-173. eCollection 2014.

The role of primary care physicians in early diagnosis and treatment of chronic gastrointestinal diseases.

Gikas A¹, Triantafillidis JK²

 

16、韩国未来的幽门螺杆菌根除趋势

Korean J Gastroenterol.2014 Mar 25;63(3):158-70.

[Future Trends of Helicobacter pylori Eradication Therapy in Korea].

[Article in Korean]

Lee JY¹, Kim N.

17、韩国和日本最新幽门螺杆菌治疗指南比较

Korean J Gastroenterol.2014 Mar 25;63(3):151-7.

[New Guidelines for Helicobacter pylori Treatment: Comparisons between Korea and Japan].

[Article in Korean]

Lee SY.

18、幽门螺杆菌治疗新措施

Korean J Gastroenterol.2014 Mar 25;63(3):146-50.

[New Therapeutic Strategies against Helicobacter pylori].

[Article in Korean]

Kang BK¹, Park SM, Kim BW.

19、韩国传统三联疗法根除幽门螺杆菌根除率的变化

Korean J Gastroenterol.2014 Mar 25;63(3):141-5.

[Changes in the Eradication Rate of Conventional Triple Therapy for Helicobacter pylori Infection in Korea].

[Article in Korean]

Heo J¹, Jeon SW.

 

20、综述：上消化道出血的药物选择：关注老人

Drugs Aging.2014 Mar 22. [Epub ahead of print]

Pharmacologic Options in the Management of Upper Gastrointestinal Bleeding: Focus on the Elderly.

Kyaw MH¹, Chan FK.

21、链酶蛋白酶可能通过消化胃黏膜粘液层，增加深层胃粘液层中抗生素的药物浓度来增强低剂量抗生素方案根除幽门螺杆菌的有效性。

Antimicrob Agents Chemother.2014 Mar 31. [Epub ahead of print]

Efficacy and pharmacological mechanism of pronase-enhanced low-dose antibiotics for Helicobacter pylori eradication.

Liu KY¹, Du FC, Fu Q, Zhang WJ, Sun HW, Zhang Y, Gan LL, Yue ZY, Zou QM, Guo G

22、幽门螺杆菌感染的非传统治疗方法

J Microbiol.2014 Apr;52(4):259-72.

Nontraditional therapies to treat Helicobacter pylori infection.

Makobongo MO¹, Gilbreath JJ, Merrell DS.

23、CYP2C19基因类型和耐药性是影响一线三联疗法根除幽门螺杆菌疗效的因素。

Dig Dis Sci. 2014 Mar 6. [Epub ahead of print]

Factors Affecting First-Line Triple Therapy of Helicobacter pylori Including CYP2C19 Genotype and Antibiotic Resistance.

Lee JY¹, Kim N, Kim MS, Choi YJ, Lee JW, Yoon H, Shin CM, Park YS, Lee DH, Jung HC.